Oscient Pharmaceuticals Corp (fka OSCIQ)

[was builder]

Found this little tid bit...

The downfall of OSCI nearly 3-months ago has triggered a stream of
corporate-restructuring business for Wall Street, an irony that isn't
lost on Mark Shapiro.
As head of the OSCI's restructuring business, it was Shapiro who
helped orchestrate OSCI's North American operations sale to Barclays
Capital, a unit of Barclays PLC (BCS). "And, it's not often a
restructuring team gets called on to restructure its firm," he said.

Also from website. Believe they still own this own.

Ramoplanin
Oscient Pharmaceuticals has conducted clinical trials for Ramoplanin for the treatment of Clostridium difficile-associated disease (CDAD). Ramoplanin has Fast-Track status from the FDA and the Company has received a Special Protocol Assessment from the FDA for the Phase III clinical trial. Based on a strategic decision to concentrate resources on building the commercial business, Oscient has been seeking to out-license, co-develop or sell the rights to Ramoplanin to a partner.


The first page of the banckruptcy filing. Bottom shows assets to liabilities. Waltham, MA-based debtor's petition lists assets of $174 million, debts as $183 million.

http://www.scribd.com/doc/17331966/Oscient-Pharmaceuticals-Chapter-11-Bankruptcy-Petition

Oscient Pharmaceuticals was founded in 1961 and is headquartered in Waltham, Massachusetts.
This company has been around forever. We may get a nice surprise with this one after all.


The United States Trustee has appointed the members of the Official Committee of Unsecured Creditors in the Oscient Pharmaceuticals Corporation bankruptcy case. Oscient Pharmaceuticals filed for bankruptcy protection recently in the District of Massachusetts bankruptcy court.

The members of the Creditors' Committee are:



•U.S. Bank, N.A. (as indenture trustee of 3.5% convertible promissory notes due in 2011)
•Motorlease Corp.
•RxSolutions, Inc.
The representative of U.S. Bank has been appointed as the chairperson of the Creditors' Committee.
http://www.netdocketsblog.com/2009/07/oscient-pharmaceuticals-creditors.html